All research
Semaglutide 2026-09-01 PubMed

OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


masld fatty-liver-disease lipid-metabolism oaf scpx siah1
Source: pubmed:42666127 · Ingested Sep 1, 2026